How Recursion is leading a new era of AI-driven drug discovery AI drug discovery is not a new phenomenon – but it is evolving at an almost dizzying pace. Recursion is one of the earliest innovators in ...
Recursion's co-founder and long-serving chief executive, Chris Gibson, has switched to the role of company chair, and will be succeeded in the CEO role by R&D and commercial head Najat Khan. The ...
The US AI research company Anthropic has become known for building powerful AI models while simultaneously warning about their dangers. “We are not there yet, and recursive self-improvement is not ...
A hobby coder's rough return to Visual Studio highlights how IntelliSense, IntelliCode and GitHub Copilot have created several overlapping layers of code completion -- along with settings intended to ...
We speak with Monocle’s Andrew Tuck and Richard Spencer-Powell about Med, Mountains & More. Plus: we hear from the editor of Italian puzzle magazine ‘La Settimana Enigmistica’ and Salomé Grouard on ...
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings.
If you are a Windows 11/10 user, you might have seen the DumpStack.log.tmp file in your C drive. This file is located in the root directory of your Windows computer. However, it is not necessary that ...
Recursion Pharmaceuticals, Inc. is a clinical-stage biotechnology company that combines automation, artificial intelligence, machine learning, and in vivo validation capabilities to discover novel ...